FGF21 is an endocrine signal of protein restriction

Journal of Clinical Investigation

Volumn 124, Issue 9, 2014, Pages 3913-3922

  Laeger, Thomas ^a   Henagan, Tara M ^a   Albarado, Diana C ^a   Redman, Leanne M ^a   Bray, George A ^a   Noland, Robert C ^a   Münzberg, Heike ^a   Hutson, Susan M ^b   Gettys, Thomas W ^a   Schwartz, Michael W ^c   Morrison, Christopher D ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FIBROBLAST GROWTH FACTOR 21; GCN2 PROTEIN; INITIATION FACTOR 2ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; UNCLASSIFIED DRUG; EIF2AK4 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; PROTEIN INTAKE; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; KETOGENIC DIET; LIVER; MALE; METABOLISM; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RESTRICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; SIGNAL TRANSDUCTION; STARVATION; WEIGHT GAIN; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; C57BL MOUSE; CALORIC RESTRICTION; ENERGY METABOLISM; GENETICS; PHYSIOLOGY; PROTEIN INTAKE; SPRAGUE DAWLEY RAT;

ANIMALS; CALORIC RESTRICTION; DIETARY PROTEINS; ENERGY METABOLISM; FIBROBLAST GROWTH FACTORS; KETOGENIC DIET; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84907015381     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74915     Document Type: Article

References (59)

1. Simpson SJ, Raubenheimer D. Geometric analysis of macronutrient selection in the rat. Appetite. 1997;28(3):201-213.
2. Sorensen A, Mayntz D, Raubenheimer D, Simpson SJ. Protein-leverage in mice: the geometry of macronutrient balancing and consequences for fat deposition. Obesity (Silver Spring). 2008;16(3):566-571.
3. Gosby AK, et al. Testing protein leverage in lean humans: a randomised controlled experimental study. PLoS One. 2011;6(10):e25929.
4. Morrison CD, Reed SD, Henagan TM. Homeostatic regulation of protein intake: in search of a mechanism. Am J Physiol Regul Integr Comp Physiol. 2012;302(8):R917-R928.
5. Potthoff MJ, Kliewer SA, Mangelsdorf DJ. Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev. 2012;26(4):312-324.
6. Potthoff MJ, et al. FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A. 2009;106(26):10853-10858.
7. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5(6):426-437.
8. Inagaki T, et al. Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5(6):415-425.
9. Kharitonenkov A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774-781.
10. Kharitonenkov A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627-1635.
11. Coskun T, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149(12):6018-6027.
12. Xu J, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250-259.
13. Fisher FM, et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26(3):271-281.
14. Zhang Y, et al. The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife. 2012;1:e00065.
15. Fisher FM, et al. Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology. 2011;152(8):2996-3004.
16. Camporez JP, et al. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology. 2013;154(9):3099-3109.
17. Hotta Y, et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology. 2009;150(10):4625-4633.
18. Sarruf DA, et al. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes. 2010;59(7):1817-1824.
19. Bookout AL, et al. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med. 2013;19(9):1147-1152.
20. Gaich G, et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013;18(3):333-340.
21. Angelin B, Larsson TE, Rudling M. Circulating fibroblast growth factors as metabolic regulators-a critical appraisal. Cell Metab. 2012;16(6):693-705.
22. Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care. 2009;32(8):1542-1546.
23. Dushay J, et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology. 2010;139(2):456-463.
24. Zhang X, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246-1253.
25. Christodoulides C, Dyson P, Sprecher D, Tsintzas K, Karpe F. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J Clin Endocrinol Metab. 2009;94(9):3594-3601.
26. Galman C, et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man. Cell Metab. 2008;8(2):169-174.
27. Schaap FG, Kremer AE, Lamers WH, Jansen PL, Gaemers IC. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. Biochimie. 2013;95(4):692-699.
28. Kim KH, et al. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochem Biophys Res Commun. 2013;440(1):76-81.
29. Keipert S, et al. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am J Physiol Endocrinol Metab. 2014;306(5):E469-E482.
30. De Sousa-Coelho AL, Marrero PF, Haro D. Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation. Biochem J. 2012;443(1):165-171.
31. Morrison CD, Xi X, White CL, Ye J, Martin RJ. Amino acids inhibit Agrp gene expression via an mTOR-dependent mechanism. Am J Physiol Endocrinol Metab. 2007;293(1):E165-E171.
32. White BD, Porter MH, Martin RJ. Effects of age on the feeding response to moderately low dietary protein in rats. Physiol Behav. 2000;68(5):673-681.
33. Kalhan SC, et al. Metabolic and genomic response to dietary isocaloric protein restriction in the rat. J Biol Chem. 2011;286(7):5266-5277.
34. Badman MK, Koester A, Flier JS, Kharitonenkov A, Maratos-Flier E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology. 2009;150(11):4931-4940.
35. Bray GA, et al. Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. JAMA. 2012;307(1):47-55.
36. Kilberg MS, Balasubramanian M, Fu L, Shan J. The transcription factor network associated with the amino acid response in mammalian cells. Adv Nutr. 2012;3(3):295-306.
37. Chaveroux C, et al. Molecular mechanisms involved in the adaptation to amino acid limitation in mammals. Biochimie. 2010;92(7):736-745.
38. Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans. 2006;34(pt 1):7-11.
39. White BD, He B, Dean RG, Martin RJ. Low protein diets increase neuropeptide Y gene expression in the basomedial hypothalamus of rats. J Nutr. 1994;124(8):1152-1160.
40. White BD, Porter MH, Martin RJ. Protein selection, food intake, and body composition in response to the amount of dietary protein. Physiol Behav. 2000;69(4):383-389.
41. Rothwell NJ, Stock MJ. Influence of carbohydrate and fat intake on diet-induced thermogenesis and brown fat activity in rats fed low protein diets. J Nutr. 1987;117(10):1721-1726.
42. Rothwell NJ, Stock MJ, Tyzbir RS. Mechanisms of thermogenesis induced by low protein diets. Metabolism. 1983;32(3):257-261.
43. Anthony TG, et al. Preservation of liver protein synthesis during dietary leucine deprivation occurs at the expense of skeletal muscle mass in mice deleted for eIF2 kinase GCN2. J Biol Chem. 2004;279(35):36553-36561.
44. Maurin AC, et al. The GCN2 kinase biases feeding behavior to maintain amino acid homeostasis in omnivores. Cell Metab. 2005;1(4):273-277.
45. Zhang P, et al. The GCN2 eIF2α kinase is required for adaptation to amino acid deprivation in mice. Mol Cell Biol. 2002;22(19):6681-6688.
46. Guo F, Cavener DR. The GCN2 eIF2α kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metab. 2007;5(2):103-114.
47. Dudek SM, Semenkovich CF. Essential amino acids regulate fatty acid synthase expression through an uncharged transfer RNA-dependent mechanism. J Biol Chem. 1995;270(49):29323-29329.
48. Xiao F, et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes. 2011;60(3):746-756.
49. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ, Kliewer SA. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008;8(1):77-83.
50. Yu J, et al. Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5. Endocrinology. 2012;153(2):750-758.
51. Chen W, et al. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J Biol Chem. 2011;286(40):34559-34566.
52. Kubicky RA, Wu S, Kharitonenkov A, De Luca F. Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology. 2012;153(5):2287-2295.
53. Owen BM, et al. FGF21 contributes to neuroendocrine control of female reproduction. Nat Med. 2013;19(9):1153-1156.
54. Tanaka T, et al. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr. 2013;97(6):1395-1402.
55. Chu AY, et al. Novel locus including FGF21 is associated with dietary macronutrient intake. Hum Mol Genet. 2013;22(9):1895-1902.
56. Levine ME, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19(3):407-417.
57. Solon-Biet SM, et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 2014;19(3):418-430.
58. Wu G, Knabe DA. Free and protein-bound amino acids in sow's colostrum and milk. J Nutr. 1994;124(3):415-424.
59. Purpera MN, et al. Impaired branched chain amino acid metabolism alters feeding behavior and increases orexigenic neuropeptide expression in the hypothalamus. J Endocrinol. 2012;212(1):85-94.